Osteopontin siRNA does not confer resistance to toxic effects of parthenolide in Jurkat cells
Summary. Background: Osteopontin (OPN) plays a critical role in cell proliferation and drug resistance in cancer treatment and hematological malignancies. In T cell acute lymphoblastic leukemia, most initial therapies can induce remission while some patients then relapse and do not respond...
Saved in:
Date: | 2023 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Published: |
PH Akademperiodyka
2023
|
Subjects: | |
Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-15 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Journal Title: | Experimental Oncology |